Combination therapy with lansoprazole and cholecalciferol is associated with a slower decline in residual beta-cell function and lower insulin requirements in children with recent onset type 1 diabetes: results of a pilot study.
Saved in:
| Title: | Combination therapy with lansoprazole and cholecalciferol is associated with a slower decline in residual beta-cell function and lower insulin requirements in children with recent onset type 1 diabetes: results of a pilot study. |
|---|---|
| Authors: | Reddy, Raghunatha1, Dayal, Devi1 drdevidayal@gmail.com, Sachdeva, Naresh1, Attri, Savita Verma1, Gupta, Vinod Kumar1 |
| Source: | Einstein (16794508). 2022, Vol. 20, p1-8. 8p. |
| Database: | Academic Search Ultimate |
| ISSN: | 16794508 |
|---|---|
| DOI: | 10.31744/einstein_journal/2022AO0149 |
